Videos

20 May 2025

The Children of the Sierra

Statements

19 May 2025

DNDi interventions at the 78^th World Health Assembly

Scientific articles

15 May 2025

Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study

Journal of Chromatography B

Press releases

13 May 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

Stories

13 May 2025

L’élimination de la maladie du sommeil en Guinée, vue de l’intérieur

Statements

8 May 2025

DNDi’s briefing note for 78^th World Health Assembly

News

30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Scientific articles

29 Apr 2025

Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study

The Lancet Global Health

Scientific articles

29 Apr 2025

Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study

The Lancet Global Health

News

25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Press releases

24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Press releases

23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease